NBIX Biotechnology / Pharmaceutical Pre-earnings LONG
Neurocrine Biosciences, a mid cap pharmaceutical firm is up for earnings on February 7th.
Investor and trader interest seems to be moderately increasing in the past week. The combined
MACD / RSI indicator is bullish. This looks good for a longtrade to be taken in the premarket
before 7:45 AM as earnings report at 8:00
Investor and trader interest seems to be moderately increasing in the past week. The combined
MACD / RSI indicator is bullish. This looks good for a longtrade to be taken in the premarket
before 7:45 AM as earnings report at 8:00
Transaction en cours:
www.prnewswire.com/n...-2024-302055386.html
The earnings report was decent but perhaps lower than trader expectations.
I expect the dip is a good entry point for an add of position.
The earnings report was decent but perhaps lower than trader expectations.
I expect the dip is a good entry point for an add of position.
Transaction en cours:
Half of the shares @ 144 and the second half @ 137 for an average of 140.5 currently
a small loss with bullish momentum as traders realize that a 20% earnings beat with flat revenue means that belt trimming has occurred which provides context to
forward guidance.
a small loss with bullish momentum as traders realize that a 20% earnings beat with flat revenue means that belt trimming has occurred which provides context to
forward guidance.
Transaction en cours:
The tourniquet did not help (LOL, IMO); I am a believer I will hold out; big wins elsewhere today. patience abounding but no more adds. Will wait for the attention for tech earnings to evaporate and see if the recovery happens.